Severe chronic rhinosinusitis patients treated with Chitogel had lower rates of revision surgery within the first 18-24 months post-operative. These findings suggest that use of Chitogel can improve long-term patient outcomes and should improve health system efficiency.
Keyphrases
- chronic rhinosinusitis
- minimally invasive
- end stage renal disease
- coronary artery bypass
- ejection fraction
- healthcare
- early onset
- public health
- chronic kidney disease
- newly diagnosed
- mental health
- peritoneal dialysis
- patient reported outcomes
- risk assessment
- health information
- atrial fibrillation
- climate change
- percutaneous coronary intervention
- human health